{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The US FDA - recommended argatroban dose in HIT is 2 microg / kg / min ( reduced in patients with hepatic impairment and in paediatric patients ) , adjusted to achieve activated partial thromboplastin times ( aPTTs ) 1 . 5 - 3 times baseline ( not > 100 seconds ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| HIT (Heparin-induced thrombocytopenia) |\n\nIn the given paragraph, the only disease entity mentioned is \"HIT\", which stands for Heparin-induced thrombocytopenia."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| HIT (Heparin-induced thrombocytopenia) |\n\nIn this paragraph, the only term that refers to a disease is \"HIT\", which stands for Heparin-induced thrombocytopenia. The other terms, such as \"hepatic impairment\" and \"paediatric patients\", are conditions or patient categories but not diseases themselves."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The US FDA - recommended argatroban dose in HIT is 2 microg / kg / min ( reduced in patients with hepatic impairment and in paediatric patients ) , adjusted to achieve activated partial thromboplastin times ( aPTTs ) 1 . 5 - 3 times baseline ( not > 100 seconds ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| argatroban |\n| 2 microg / kg / min |\n| patients with hepatic impairment |\n| paediatric patients |\n| activated partial thromboplastin times (aPTTs) |\n| 1.5 - 3 times baseline |\n| not > 100 seconds |\n\nExplanation:\n\n* \"argatroban\" is a chemical (a drug)\n* \"2 microg / kg / min\" is a rate of administration of a chemical substance (argatroban)\n* \"hepatic impairment\" is a condition that can affect the metabolism of chemical substances (like argatroban)\n* \"paediatric patients\" are a group of people who may have different responses to chemical substances (like argatroban)\n* \"activated partial thromboplastin times (aPTTs)\" is a chemical test used to monitor the effect of anticoagulant drugs (like argatroban)\n* \"1.5 - 3 times baseline\" and \"not > 100 seconds\" are target ranges for the aPTT test, which is a chemical measurement."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| argatroban |\n\nExplanation:\n\n* \"argatroban\" is the only clear chemical entity in the paragraph.\n* \"2 microg / kg / min\" is a rate of administration of a chemical substance, but it is not a chemical itself.\n* \"hepatic impairment\" and \"paediatric patients\" are medical conditions or patient groups, not chemicals.\n* \"activated partial thromboplastin times (aPTTs)\" is a chemical test, but it is not a chemical substance.\n* \"1.5 - 3 times baseline\" and \"not > 100 seconds\" are target ranges for the aPTT test, which is a chemical measurement, but they are not chemical entities."}
  ]
}